E Fürer

2.6k total citations
64 papers, 2.1k citations indexed

About

E Fürer is a scholar working on Immunology, Epidemiology and Endocrinology. According to data from OpenAlex, E Fürer has authored 64 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 17 papers in Epidemiology and 17 papers in Endocrinology. Recurrent topics in E Fürer's work include Pneumonia and Respiratory Infections (11 papers), Antibiotic Resistance in Bacteria (11 papers) and Immune Response and Inflammation (11 papers). E Fürer is often cited by papers focused on Pneumonia and Respiratory Infections (11 papers), Antibiotic Resistance in Bacteria (11 papers) and Immune Response and Inflammation (11 papers). E Fürer collaborates with scholars based in Switzerland, United States and United Kingdom. E Fürer's co-authors include Stanley J. Cryz, R. Germanier, Jerald Sadoff, Aloïs B. Lang, J U Que, S J Cryz, Alan S. Cross, Tyrone L. Pitt, J Wedgwood and John U. Que and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Blood.

In The Last Decade

E Fürer

64 papers receiving 1.9k citations

Peers

E Fürer
R. Germanier Switzerland
Teresa M. Brown United States
Frida Stock United States
Carla R. Clausen United States
Hester J. Bootsma Netherlands
Janet Yother United States
E Fürer
Citations per year, relative to E Fürer E Fürer (= 1×) peers Lucy M. Mutharia

Countries citing papers authored by E Fürer

Since Specialization
Citations

This map shows the geographic impact of E Fürer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Fürer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Fürer more than expected).

Fields of papers citing papers by E Fürer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Fürer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Fürer. The network helps show where E Fürer may publish in the future.

Co-authorship network of co-authors of E Fürer

This figure shows the co-authorship network connecting the top 25 collaborators of E Fürer. A scholar is included among the top collaborators of E Fürer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Fürer. E Fürer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kantele, Anu, Heikki Arvilommi, Erkki Savilahti, et al.. (2004). Unique Characteristics of the Intestinal Immune System as an Inductive Site after Antigen Reencounter. The Journal of Infectious Diseases. 191(2). 312–317. 27 indexed citations
2.
Lang, Aloïs B., A Rüdeberg, Martin H. Schöni, et al.. (2004). Vaccination of Cystic Fibrosis Patients Against Pseudomonas aeruginosa Reduces the Proportion of Patients Infected and Delays Time to Infection. The Pediatric Infectious Disease Journal. 23(6). 504–510. 67 indexed citations
3.
Cross, Alan S., Steven M. Opal, Apurba K. Bhattacharjee, et al.. (1999). Immunotherapy of sepsis: flawed concept or faulty implementation?. Vaccine. 17. S13–S21. 20 indexed citations
4.
Thisyakorn, Usa, et al.. (1997). A brief update on the diagnosis of trichinellosis.. PubMed. 28(1). 91–8. 5 indexed citations
5.
Lang, Aloïs B., Urs B. Schaad, A Rüdeberg, et al.. (1995). Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis. The Journal of Pediatrics. 127(5). 711–717. 41 indexed citations
6.
Cryz, Stanley J., Harris Goldstein, Massimo Pettoello‐Mantovani, et al.. (1995). Human immunodeficiency virus-1 principal neutralizing domain peptide-toxin A conjugate vaccine. Vaccine. 13(1). 67–71. 4 indexed citations
7.
Cross, Alan S., Andrew W. Artenstein, Jianwen Que, et al.. (1994). Safety And Immunogenicity Of A Polyvalent Escherichia Coli Vaccine In Human Volunteers. The Journal of Infectious Diseases. 170(4). 834–840. 31 indexed citations
8.
Cryz, Stanley J., J Wedgwood, Aloïs B. Lang, et al.. (1994). Immunization of Noncolonized Cystic Fibrosis Patients against Pseudomonas aeruginosa. The Journal of Infectious Diseases. 169(5). 1159–1162. 30 indexed citations
9.
Cryz, Stanley J., Harris Goldstein, E Fürer, et al.. (1993). Prospects for Prevention of Vertical Transmission of Human Immunodeficiency Virus by Immunization. Annals of the New York Academy of Sciences. 693(1). 194–201. 1 indexed citations
10.
Schaad, U. B., J Wedgwood, Aloïs B. Lang, et al.. (1991). Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis. The Lancet. 338(8777). 1236–1237. 68 indexed citations
11.
Cryz, Stanley J., Alan S. Cross, Jerald Sadoff, et al.. (1991). Safety and Immunogenicity of Escherichia coli 018 O-Specific Polysaccharide (O-PS)-Toxin A and O-PS-Cholera Toxin Conjugate Vaccines in Humans. The Journal of Infectious Diseases. 163(5). 1040–1045. 23 indexed citations
12.
Bruderer, Urs, E Fürer, Stanley J. Cryz, & Aloïs B. Lang. (1990). Qualitative analysis of antibody binding. Journal of Immunological Methods. 133(2). 263–268. 10 indexed citations
13.
Cryz, S J, Myron M. Levine, James B. Kaper, E Fürer, & Beat Althaus. (1990). Randomized double-blind placebo controlled trial to evaluate the safety and immunogenicity of the live oral cholera vaccine strain CVD 103-HgR in Swiss adults. Vaccine. 8(6). 577–580. 52 indexed citations
14.
Würgler, F.E., et al.. (1990). Salmonella/mammalian microsome assay with tetranitromethane and 3-nitro-l-tyrosine. Mutation Research Letters. 244(1). 7–14. 1 indexed citations
15.
Cryz, S J, Jerald Sadoff, & E Fürer. (1989). Octavalent Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine. Microbial Pathogenesis. 6(1). 75–80. 36 indexed citations
16.
Ohman, Dennis E., et al.. (1988). Characterization of the human immune response to a Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.. PubMed. 111(6). 701–7. 27 indexed citations
17.
Fürer, E, et al.. (1988). [Effectiveness of oral, attenuated live Salmonella typhi Ty 21a vaccine in controlled field trials].. PubMed. 118(13). 467–70. 4 indexed citations
18.
Cryz, Stanley J., E Fürer, & R. Germanier. (1985). Purification and vaccine potential of Klebsiella capsular polysaccharides. Infection and Immunity. 50(1). 225–230. 46 indexed citations
19.
Pierce, N. F., William C. Cray, John B. Sacci, et al.. (1983). Procholeragenoid: a safe and effective antigen for oral immunization against experimental cholera. Infection and Immunity. 40(3). 1112–1118. 27 indexed citations
20.
Cryz, Stanley J., E Fürer, & R. Germanier. (1983). Protection against Pseudomonas aeruginosa infection in a murine burn wound sepsis model by passive transfer of antitoxin A, antielastase, and antilipopolysaccharide. Infection and Immunity. 39(3). 1072–1079. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026